
From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches are redefining patient outcomes.
Leonard K. Seibold, MD, is Professor of Ophthalmology, Glaucoma Service Chief and Fellowship Director, University of Colorado School of Medicine. Seibold consults for AbbVie, New World Medical, and Thea.

From MIGS integration to remote monitoring and next-generation therapeutics, glaucoma specialists explore how new approaches are redefining patient outcomes.